Pfiz­er inks an ear­ly-stage col­lab­o­ra­tion deal as it in­vests in an­oth­er start­up; Stem cell start­up lands car­diac tech

A busy Pfiz­er is part­ner­ing with South San Fran­cis­co-based Ab Ini­tio Bio­ther­a­peu­tics on the dis­cov­ery of new GPCR ac­ti­va­tor drugs. Pfiz­er is in­vest­ing in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.